about
CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment.CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis.Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion currentIn vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumorsA Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic Process.Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells.Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cellsNew molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells.Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System.Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies.Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds.The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma.Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets.Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA.The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cellsIsolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potential.Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas.Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors.In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity.Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature.Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins.Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell Viability
P50
Q33677057-4032A01F-C401-493B-AB6D-93F70039CDF9Q34195197-2D7DDF30-7C8E-456A-978D-8598E98CBCE5Q34957274-53FC66EB-F9ED-4054-AF61-5FAF98658D14Q35425337-C437E09B-7974-4F4F-B18A-78EC8A8CE878Q36243278-F821E248-3B0F-4F28-B58D-7B29E9C2E01FQ36604614-D4AF4B3E-F483-401C-B6B2-A826401F3511Q37368670-0F521D95-AF54-4E9A-879B-BFE377E24E78Q37437614-2AAB4081-BBC1-4BD7-888F-F0BC56DB2F9AQ38187997-E0CB78FD-7916-4829-BE4D-310117809AFAQ38284921-44DB2B65-DFB8-452E-96E1-83E73DA75342Q38560361-184C5BF4-3027-4E2E-9400-4C996D1059C4Q38604588-9677B5AF-10A9-4A4C-BFC5-6B4A885EE00DQ38819651-175C1C5A-78C4-4D9F-A385-26C14DB035DBQ38947056-271FAAEB-FA07-4572-B86D-BDBCB6CAB603Q39071024-767B7A08-B92C-47A3-8B61-643346071385Q39501185-BAD50AA8-BA65-441A-88F4-7F1DBB4DCFA6Q42019935-504DE359-8370-4132-895D-25CC4D52BE86Q42038363-EE2D1476-D38D-4961-922F-0C6A9CF2A564Q44823654-0A6CA5AE-B009-46F4-A54C-A5C9B462D00FQ48116589-7EC25A6D-5E7B-4ABC-9F6C-BC0FF6AF93A0Q48132665-18509C79-D216-4B12-98AF-A218D6397741Q48548827-F518A0B0-6E49-455F-8B12-22517CBABE4DQ51603782-BFBDB2F4-491D-406D-9E20-676593B68137Q54353594-E2967537-0079-4083-9CDC-4F7C7679AF1FQ58728819-CA96C1B8-0E05-40A0-95E5-F5D7C2451E75
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Roberto Würth
@ast
Roberto Würth
@en
Roberto Würth
@es
Roberto Würth
@nl
type
label
Roberto Würth
@ast
Roberto Würth
@en
Roberto Würth
@es
Roberto Würth
@nl
prefLabel
Roberto Würth
@ast
Roberto Würth
@en
Roberto Würth
@es
Roberto Würth
@nl
P106
P1153
23096681000
P21
P31
P496
0000-0002-8156-6756